4.6 Article

Noncontrast T1 Mapping for the Diagnosis of Cardiac Amyloidosis

期刊

JACC-CARDIOVASCULAR IMAGING
卷 6, 期 4, 页码 488-497

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jcmg.2012.11.013

关键词

amyloid; cardiovascular magnetic resonance; T1 time

资金

  1. National Institute for Health Research, Oxford Biomedical Research Centre Programme
  2. GlaxoSmithKline
  3. Alberta Innovates Health Solutions Clinical Fellowship
  4. University of Oxford Clarendon Fund Scholarship
  5. Oxford British Heart Foundation Centre of Research Excellence
  6. Higher Education Funding Council for England
  7. Department of Health NIHR Biomedical Research Centres funding scheme
  8. British Heart Foundation [FS/10/015/28104, FS/12/56/29723, FS/10/40/28260] Funding Source: researchfish
  9. Medical Research Council [G0700796] Funding Source: researchfish
  10. National Institute for Health Research [NF-SI-0512-10005] Funding Source: researchfish
  11. MRC [G0700796] Funding Source: UKRI

向作者/读者索取更多资源

OBJECTIVES This study sought to explore the potential role of noncontrast myocardial T1 mapping for detection of cardiac involvement in patients with primary amyloid light-chain (AL) amyloidosis. BACKGROUND Cardiac involvement carries a poor prognosis in systemic AL amyloidosis. Late gadolinium enhancement (LGE) cardiac magnetic resonance (CMR) is useful for the detection of cardiac amyloid, but characteristic LGE patterns do not always occur or they appear late in the disease. Noncontrast characterization of amyloidotic myocardium with T1 mapping may improve disease detection. Furthermore, quantitative assessment of myocardial amyloid load would be of great value. METHODS Fifty-three AL amyloidosis patients (14 with no cardiac involvement, 11 with possible involvement, and 28 with definite cardiac involvement based on standard biomarker and echocardiographic criteria) underwent CMR (1.5-T) including noncontrast T1 mapping (shortened modified look-locker inversion recovery [ShMOLLI] sequence) and LGE imaging. These were compared with 36 healthy volunteers and 17 patients with aortic stenosis and a comparable degree of left ventricular hypertrophy as the cardiac amyloid patients. RESULTS Myocardial T1 was significantly elevated in cardiac AL amyloidosis patients (1,140 +/- 61 ms) compared to normal subjects (958 +/- 20 ms, p < 0.001) and patients with aortic stenosis (979 +/- 51 ms, p < 0.001). Myocardial T1 was increased in AL amyloid even when cardiac involvement was uncertain (1,048 +/- 48 ms) or thought absent (1,009 +/- 31 ms). A noncontrast myocardial T1 cutoff of 1,020 ms yielded 92% accuracy for identifying amyloid patients with possible or definite cardiac involvement. In the AL amyloidosis cohort, there were significant correlations between myocardial T1 time and indices of systolic and diastolic dysfunction. CONCLUSIONS Noncontrast T1 mapping has high diagnostic accuracy for detecting cardiac AL amyloidosis, correlates well with markers of systolic and diastolic dysfunction, and is potentially more sensitive for detecting early disease than LGE imaging. Elevated myocardial T1 may represent a direct marker of cardiac amyloid load. Further studies are needed to assess the prognostic significance of T1 elevation. (J Am Coll Cardiol Img 2013;6:488-97) (C) 2013 by the American College of Cardiology Foundation

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据